NKGen Biotech Inc. (NKGN:OTC) closed at $0.060 on February 5, 2026, unchanged on the day. The stock trades 70.0% below its 52-week high of $0.200 and 5,900.0% above its 52-week low of $0.001. NKGen Biotech Inc. is part of the Health Care sector.
NKGen Biotech is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies to treat neurodegenerative and oncological diseases utilizing our proprietary SNK (super-activated) platform. Spearheading our industry disrupting technology are our Senior Leadership, Senior Advisors and Management Team. Together they bring a wealth of knowledge and expertise in neurodegeneration and immune-oncology and are passionate and excited about the work we are doing to strengthen the immune system.
Find more stocks like NKGN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.